Doris Tomas

1.9k total citations
30 papers, 923 citations indexed

About

Doris Tomas is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Doris Tomas has authored 30 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 15 papers in Cellular and Molecular Neuroscience and 9 papers in Molecular Biology. Recurrent topics in Doris Tomas's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Amyotrophic Lateral Sclerosis Research (8 papers) and Neurological disorders and treatments (7 papers). Doris Tomas is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Amyotrophic Lateral Sclerosis Research (8 papers) and Neurological disorders and treatments (7 papers). Doris Tomas collaborates with scholars based in Australia, United States and New Zealand. Doris Tomas's co-authors include Malcolm Horne, David I. Finkelstein, Davor Stanić, Clare L. Parish, Bradley J. Turner, M.K. Horne, Kerry Dickson, Nirma D. Perera, John Drago and Tim D. Aumann and has published in prestigious journals such as PLoS ONE, Brain and The Journal of Comparative Neurology.

In The Last Decade

Doris Tomas

29 papers receiving 909 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doris Tomas Australia 16 408 395 293 152 104 30 923
Shane V. Hegarty Ireland 17 177 0.4× 399 1.0× 499 1.7× 92 0.6× 71 0.7× 27 989
David J. Eve United States 18 422 1.0× 470 1.2× 464 1.6× 130 0.9× 173 1.7× 33 1.2k
Sarah Morgan Germany 20 515 1.3× 428 1.1× 271 0.9× 202 1.3× 150 1.4× 38 1.1k
Satoshi Kaneko Japan 16 479 1.2× 364 0.9× 419 1.4× 95 0.6× 156 1.5× 58 1.2k
Florian Giesert Germany 17 419 1.0× 323 0.8× 446 1.5× 124 0.8× 167 1.6× 26 1.0k
Yasuhiro Kawamoto Japan 20 522 1.3× 486 1.2× 469 1.6× 263 1.7× 203 2.0× 46 1.3k
Alissa L. Nana United States 16 544 1.3× 310 0.8× 421 1.4× 149 1.0× 320 3.1× 27 1.1k
Kanehiro Hayashi Japan 19 268 0.7× 505 1.3× 549 1.9× 82 0.5× 111 1.1× 31 1.4k
Kayoko Tsukita Japan 16 350 0.9× 300 0.8× 640 2.2× 195 1.3× 307 3.0× 36 1.1k
Agnieszka Ciesielska Poland 22 335 0.8× 406 1.0× 329 1.1× 284 1.9× 175 1.7× 32 1.1k

Countries citing papers authored by Doris Tomas

Since Specialization
Citations

This map shows the geographic impact of Doris Tomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris Tomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris Tomas more than expected).

Fields of papers citing papers by Doris Tomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris Tomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris Tomas. The network helps show where Doris Tomas may publish in the future.

Co-authorship network of co-authors of Doris Tomas

This figure shows the co-authorship network connecting the top 25 collaborators of Doris Tomas. A scholar is included among the top collaborators of Doris Tomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doris Tomas. Doris Tomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haidar, Mouna, Doris Tomas, Samuel A. Mills, et al.. (2025). Cortical hyperexcitability drives dying forward amyotrophic lateral sclerosis symptoms and pathology in mice. Progress in Neurobiology. 252. 102809–102809.
2.
Perera, Nirma D., Doris Tomas, Mona Radwan, et al.. (2024). Systemic administration of a novel Beclin 1-derived peptide significantly upregulates autophagy in the spinal motor neurons of autophagy reporter mice. International Journal of Pharmaceutics. 659. 124198–124198. 1 indexed citations
3.
Tomas, Doris, et al.. (2024). Efficient systemic CNS delivery of a therapeutic antisense oligonucleotide with a blood-brain barrier-penetrating ApoE-derived peptide. Biomedicine & Pharmacotherapy. 175. 116737–116737. 10 indexed citations
4.
Perera, Nirma D., et al.. (2021). Stimulation of mTOR-independent autophagy and mitophagy by rilmenidine exacerbates the phenotype of transgenic TDP-43 mice. Neurobiology of Disease. 154. 105359–105359. 17 indexed citations
5.
Tomas, Doris, Nirma D. Perera, Sophia J. Luikinga, et al.. (2021). Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis. Cell Death and Differentiation. 29(6). 1187–1198. 123 indexed citations
6.
Barton, Samantha K., Chew L. Lau, Doris Tomas, et al.. (2020). Mutant TDP-43 Expression Triggers TDP-43 Pathology and Cell Autonomous Effects on Primary Astrocytes: Implications for Non-cell Autonomous Pathology in ALS. Neurochemical Research. 45(6). 1451–1459. 10 indexed citations
7.
Perera, Nirma D., Doris Tomas, André L. Samson, et al.. (2019). Necroptosis is dispensable for motor neuron degeneration in a mouse model of ALS. Cell Death and Differentiation. 27(5). 1728–1739. 59 indexed citations
8.
Stephenson, Sarah, Juliet M. Taylor, Jessica R. Riseley, et al.. (2018). Generation and characterisation of a parkin-Pacrg knockout mouse line and a Pacrg knockout mouse line. Scientific Reports. 8(1). 7528–7528. 13 indexed citations
9.
Sheean, Rebecca K., Fiona C. McKay, Erika Cretney, et al.. (2018). Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis. JAMA Neurology. 75(6). 681–681. 122 indexed citations
10.
Aumann, Tim D., et al.. (2016). Differences in Number of Midbrain Dopamine Neurons Associated with Summer and Winter Photoperiods in Humans. PLoS ONE. 11(7). e0158847–e0158847. 36 indexed citations
11.
Tomas, Doris, et al.. (2016). Restoration of the Dopamine Transporter through Cell Therapy Improves Dyskinesia in a Rat Model of Parkinson’s Disease. PLoS ONE. 11(4). e0153424–e0153424. 7 indexed citations
12.
Tomas, Doris, et al.. (2015). Environmental Modulations of the Number of Midbrain Dopamine Neurons in Adult Mice. Journal of Visualized Experiments. 52329–52329. 11 indexed citations
13.
Moses, David, et al.. (2010). Creating a Ventral Midbrain Stem Cell Niche in an Animal Model for Parkinson's Disease. Stem Cells and Development. 19(12). 1995–2007. 1 indexed citations
14.
Lee, Joohyung, Clare L. Parish, Doris Tomas, & Malcolm Horne. (2010). Chronic cocaine administration reduces striatal dopamine terminal density and striatal dopamine release which leads to drug-seeking behaviour. Neuroscience. 174. 143–150. 17 indexed citations
15.
Aumann, Tim D., et al.. (2008). SK channel function regulates the dopamine phenotype of neurons in the substantia nigra pars compacta. Experimental Neurology. 213(2). 419–430. 34 indexed citations
16.
Lee, Joohyung, Davor Stanić, David I. Finkelstein, et al.. (2008). Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia. Brain. 131(6). 1574–1587. 71 indexed citations
18.
Crompton, Kylie, et al.. (2006). Inflammatory response on injection of chitosan/GP to the brain. Journal of Materials Science Materials in Medicine. 17(7). 633–639. 39 indexed citations
19.
Finkelstein, David I., et al.. (2001). Projections from the substantia nigra pars reticulata to the motor thalamus of the rat: Single axon reconstructions and immunohistochemical study. The Journal of Comparative Neurology. 440(1). 20–30. 53 indexed citations
20.
Finkelstein, David I., Davor Stanić, Clare L. Parish, et al.. (2000). Axonal sprouting following lesions of the rat substantia nigra. Neuroscience. 97(1). 99–112. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026